Advertisement
Canada markets closed

  • S&P/TSX

    21,807.37
    +98.93 (+0.46%)
     

  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     

  • DOW

    37,986.40
    +211.02 (+0.56%)
     

  • CAD/USD

    0.7274
    +0.0010 (+0.14%)
     

  • CRUDE OIL

    83.34
    +0.61 (+0.74%)
     

  • Bitcoin CAD

    87,916.09
    +583.39 (+0.67%)
     

  • CMC Crypto 200

    1,376.80
    +64.18 (+4.89%)
     

  • GOLD FUTURES

    2,405.00
    +7.00 (+0.29%)
     

  • RUSSELL 2000

    1,947.66
    +4.70 (+0.24%)
     

  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     

  • NASDAQ

    15,282.01
    -319.49 (-2.05%)
     

  • VOLATILITY

    18.71
    +0.71 (+3.94%)
     

  • FTSE

    7,895.85
    +18.80 (+0.24%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6822
    +0.0001 (+0.01%)
     
MARKETS LIVE BLOG:

S&P 500 SLIPS BELOW 5,000; NASDAQ SINKS ON TECH DRAG

Nvidia tumbles 10%, Amazon loses more than 2% while Apple ends 1% lower

Today's Research Reports on Cipher Pharmaceuticals, Aurinia Pharmaceuticals, GeneNews and Neovasc

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / July 30, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI Initiates Coverage on:

Cipher Pharmaceuticals Inc.
https://rdinvesting.com/news/?ticker=CPH.TO

Aurinia Pharmaceuticals Inc.
https://rdinvesting.com/news/?ticker=AUP.TO

GeneNews Limited
https://rdinvesting.com/news/?ticker=GEN.TO

Neovasc Inc.
https://rdinvesting.com/news/?ticker=NVCN.TO

ADVERTISEMENT

Cipher Pharmaceuticals' stock had no change Friday, to close the day at $2.76. The stock recorded a trading volume of 200 shares, which was below its three months average volume of 24,337 shares. In the last year, Cipher Pharmaceuticals' shares have traded in a range of 2.65 - 5.75. The stock is currently trading 52.00% below its 52 week high. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $3.10 is below its 200-day moving average of $3.89. Shares of Cipher Pharmaceuticals are trading at a Price to Earnings ratio of 11.55. Shares of Cipher Pharmaceuticals have fallen approximately 43.67 percent year-to-date.

Access RDI's Cipher Pharmaceuticals Inc. Research Report at:
https://rdinvesting.com/news/?ticker=CPH.TO

On Friday, shares of Aurinia Pharmaceuticals recorded a trading volume of 29,504 shares, which was below the three months average volume of 33,287 shares. The stock ended the day 1.06% lower at 7.46. The share price has gained 31.34% from its 52 week low with a 52 week trading range of 5.68 - 9.50. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $7.55 is greater than its 200-day moving average of $7.11. Shares of Aurinia Pharmaceuticals have gained approximately 30.42 percent year-to-date.

Access RDI's Aurinia Pharmaceuticals Inc. Research Report at:
https://rdinvesting.com/news/?ticker=AUP.TO

GeneNews' stock had no change Friday, to close the day at $0.075. The stock recorded a trading volume of 15,000 shares, which was below its three months average volume of 121,565 shares. In the last year, GeneNews' shares have traded in a range of 0.07 - 0.24. The stock is currently trading 68.75% below its 52 week high. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.08 is below its 200-day moving average of $0.103. Shares of GeneNews have fallen approximately 65.22 percent year-to-date.

Access RDI's GeneNews Limited Research Report at:
https://rdinvesting.com/news/?ticker=GEN.TO

On Friday, shares of Neovasc recorded a trading volume of 241,058 shares, which was below the three months average volume of 3,248,149 shares. The stock ended the day 5.56% lower at 0.0425. The stock is currently trading 98.17% below its 52 week high with a 52 week trading range of 0.04 - 2.32. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.05 is below its 200-day moving average of $0.2833. Shares of Neovasc have fallen approximately 94.33 percent year-to-date.

Access RDI's Neovasc Inc. Research Report at:
https://rdinvesting.com/news/?ticker=NVCN.TO

Our Actionable Research on Cipher Pharmaceuticals Inc. (TSX: CPH.TO) and Aurinia Pharmaceuticals Inc. (TSX: AUP.TO) and GeneNews Limited (TSX: GEN.TO) and Neovasc Inc. (TSX: NVCN.TO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com